Direkt zum Inhalt
Merck
  • Functional evaluation using multifocal electroretinogram after selective retina therapy with a microsecond-pulsed laser.

Functional evaluation using multifocal electroretinogram after selective retina therapy with a microsecond-pulsed laser.

Investigative ophthalmology & visual science (2014-12-17)
Hoon Dong Kim, Jung Woo Han, Young-Hoon Ohn, Ralf Brinkmann, Tae Kwann Park
ZUSAMMENFASSUNG

To evaluate the changes of retinal function with multifocal electroretinogram (mfERG), and estimate the association between functional and structural changes after selective retina therapy (SRT) with microsecond-pulsed laser in comparison to continuous wave laser photocoagulation (cwPC). Selective retina therapy and cwPC were applied with 10 × 10 shots and 1/2 lesion-width on the retina in the right and left eyes of 20 healthy Chinchilla Bastard rabbits, respectively. Optical coherence tomography (OCT), fundus fluorescein angiography (FFA), and mfERG were performed before, and on days 1, 7, and 30 after both laser treatments. The mean ratios of amplitudes and implicit times of N1 and P1 from eight hexagons covering laser-treated retinal lesions/total retina were measured. Histology was obtained after killing three rabbits at each time period to observe the anatomic changes after both laser treatments. The mean ratios of amplitudes of N1 and P1 in SRT lesions did not change significantly for 30 days after laser treatment. Only subtle reductions of the mean ratios of N1 and P1 amplitudes on day 1, thereafter the amplitudes showed the trend to recover toward baseline values. Histology and OCT revealed temporary and reversible morphologic changes after SRT, which restored to normal within 1 month. However, the mean ratios of N1 amplitudes on days 7 and 30 (P = 0.010, P < 0.001, respectively), and P1 amplitudes on days 7 and 30 (P < 0.001, P < 0.001, respectively) declined significantly in cwPC lesions compared with baseline. Disorganization and atrophic changes were identified on histology and OCT after cwPC. The results suggest that SRT preserved retinal function as well as anatomical structure after treatment.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Salzsäure, ACS reagent, 37%
Sigma-Aldrich
Salzsäure, ACS reagent, 37%
Sigma-Aldrich
Chlorwasserstoff -Lösung, 4.0 M in dioxane
Sigma-Aldrich
Salzsäure -Lösung, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Salzsäure, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
Salzsäure, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Chlorwasserstoff -Lösung, 2.0 M in diethyl ether
Sigma-Aldrich
Salzsäure, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Supelco
Salzsäure -Lösung, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Fluorescein, for fluorescence, free acid
Sigma-Aldrich
Chlorwasserstoff -Lösung, 1.0 M in diethyl ether
Sigma-Aldrich
Chlorwasserstoff, ReagentPlus®, ≥99%
Sigma-Aldrich
(R)-(−)-Phenylephrin -hydrochlorid, powder
Sigma-Aldrich
Salzsäure -Lösung, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
Chlorwasserstoff -Lösung, 3 M in cyclopentyl methyl ether (CPME)
USP
Phenylephrin -hydrochlorid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Salzsäure -Lösung, 32 wt. % in H2O, FCC
Sigma-Aldrich
Chlorwasserstoff -Lösung, 1.0 M in acetic acid
Supelco
Phenylephrin-Hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Xylazin -hydrochlorid, ≥99.0% (HPLC)
Supelco
Chlorwasserstoff – Methanol -Lösung, ~1.25 m HCl (T), for GC derivatization, LiChropur
Supelco
Salzsäure – Ethanol -Lösung, ~1.25 M HCl, for GC derivatization, LiChropur
Supelco
Chlorwasserstoff–2-Propanol -Lösung, ~1.25 M HCl (T), for GC derivatization, LiChropur
Fluorescein, European Pharmacopoeia (EP) Reference Standard
Phenylephrinhydrochlorid für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Phenylephrin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
(R)-(−)-Phenylephrin -hydrochlorid, analytical standard
Xylazin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard